Human papillomavirus vaccine recombinant monovalent - VirionicsAlternative Names: CerVax; Human papillomavirus type 16 L1 virus-like particle vaccine - Virionics
Latest Information Update: 27 Mar 2008
At a glance
- Originator Virionics
- Class Cancer vaccines; Papillomavirus vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Human papillomavirus infections
Most Recent Events
- 27 Mar 2008 Discontinued - Phase-I/II for Human papillomavirus infections in USA (Parenteral)